<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP07853378A2" file="07853378.3" lang="en" country="EP" doc-number="2107910" kind="A2" date-publ="20091014" status="n" dtd-version="ep-patent-document-v1-4"><SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..MT..........................</B001EP><B003EP>*</B003EP><B005EP>X</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  1100000/0</B007EP></eptags></B000><B100><B110>2107910</B110><B130>A2</B130><B140><date>20091014</date></B140><B190>EP</B190></B100><B200><B210>07853378.3</B210><B220><date>20071214</date></B220><B230><B238EP><date>20090713</date></B238EP></B230><B240><B241><date>20090713</date></B241></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>874572 P</B310><B320><date>20061213</date></B320><B330><ctry>US</ctry></B330><B310>897096 P</B310><B320><date>20070124</date></B320><B330><ctry>US</ctry></B330><B310>2752</B310><B320><date>20071109</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20091014</date><bnum>200942</bnum></B405><B430><date>20091014</date><bnum>200942</bnum></B430></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  47/48        20060101AFI20090910BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  41/00        20060101ALI20090910BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>POLYMER-ARZNEIMITTEL-KONJUGATE MIT HALTEGRUPPEN FÜR DIE KONTROLLIERTE FREIGABE VON ARZNEIMITTELN</B542><B541>en</B541><B542>POLYMER-DRUG CONJUGATES WITH TETHER GROUPS FOR CONTROLLED DRUG DELIVERY</B542><B541>fr</B541><B542>POLYMÈRES À BASE DE CYCLODEXTRINE POUR ADMINISTRATION D'AGENTS THÉRAPEUTIQUES</B542></B540></B500><B700><B710><B711><snm>Insert Therapeutics, Inc.</snm><iid>08269360</iid><irf>P33969EP-PCT</irf><adr><str>129 North Hill Avenue, Suite 104</str><city>Pasadena, CA 91106</city><ctry>US</ctry></adr></B711></B710><B720><B721><snm>DAVIS, Mark E.</snm><adr><str>575 Laguna Road</str><city>Pasadena, CA 91105</city><ctry>US</ctry></adr></B721><B721><snm>HWANG, Jungyeon</snm><adr><str>17740 Merridy Street
Unit 14</str><city>Northridge, CA 91325</city><ctry>US</ctry></adr></B721><B721><snm>KE, Tianyi</snm><adr><str>38 Bonita Street
Unit B</str><city>Arcadia, CA 91006</city><ctry>US</ctry></adr></B721><B721><snm>LIM, Jing-jou</snm><adr><str>3425 Lebon Drive
Apt. 915</str><city>San Diego, CA 92122</city><ctry>US</ctry></adr></B721><B721><snm>SCHLUEP, Thomas</snm><adr><str>3030 Hemosa Avenue</str><city>La Crescenta, CA 91214</city><ctry>US</ctry></adr></B721></B720><B740><B741><snm>Adams, Harvey Vaughan John</snm><iid>00093861</iid><adr><str>Mathys &amp; Squire LLP 
120 Holborn</str><city>London
EC1N 2SQ</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2007025551</anum></dnum><date>20071214</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2008076333</pnum></dnum><date>20080626</date><bnum>200826</bnum></B871></B870><B880><date>20090409</date><bnum>000000</bnum></B880></B800></SDOBI></ep-patent-document>